NAGE · Niagen Bioscience, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-30 | Fried Robert N |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Shares acquired pursuant to the Issuer's Employee Stock Purchase Plan. The acquisition is exempt under Rule 16b-3(c) and 16b-3(d). |
Common Stock
|
1,106 |
| 2026-06-30 | Pamir Ozan |
CFO |
Award↑
Filing footnotes — Common Stock (Direct)
Shares acquired pursuant to the Issuer's Employee Stock Purchase Plan. The acquisition is exempt under Rule 16b-3(c) and 16b-3(d). |
Common Stock
|
4,255 |
| 2026-06-30 | Lopez Carlos Luis |
SVP, General Counsel |
Award↑
Filing footnotes — Common Stock (Direct)
Shares acquired pursuant to the Issuer's Employee Stock Purchase Plan. The acquisition is exempt under Rule 16b-3(c) and 16b-3(d). |
Common Stock
|
2,314 |
| 2026-06-24 | Patrick Kristin |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 24, 2027. |
Stock Option (right to buy)
|
31,746 |
| 2026-06-24 | Ng Wang Yu Gary |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 24, 2027. |
Stock Option (right to buy)
|
31,746 |
| 2026-06-24 | YU Wing Tak Wendy |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 24, 2027. |
Stock Option (right to buy)
|
31,746 |
| 2026-06-24 | Jaksch Frank L Jr |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 24, 2027. |
Stock Option (right to buy)
|
31,746 |
| 2026-06-24 | Rubin Steven D |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 24, 2027. |
Stock Option (right to buy)
|
31,746 |
| 2026-06-24 | Cohen Ann |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 24, 2027. |
Stock Option (right to buy)
|
31,746 |
| 2026-06-24 | Shahbazi Hamed |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 24, 2027. |
Stock Option (right to buy)
|
31,746 |
| 2026-04-24 | Fried Robert N |
Director, Chief Executive Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
The Reporting Person exercised the stock options reported on this Form 4 in advance of their expiration on November 15, 2026, paying the exercise price with cash, and has not sold any of the shares received upon exercise. |
Common Stock
|
20,000 |
| 2026-04-24 | Fried Robert N |
Director, Chief Executive Officer |
Convert↓
|
Stock Options (right to buy)
|
20,000 |
| 2026-02-19 | Pamir Ozan |
CFO |
Award↑
Filing footnotes — Employee Stock Options (right to buy) (Direct)
One-fourth of the shares subject to the option shall vest on each anniversary of the grant date. |
Employee Stock Options (right to buy)
|
62,131 |
| 2026-02-19 | Fried Robert N |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Employee Stock Options (right to buy) (Direct)
One-fourth of the shares subject to the option shall vest on each anniversary of the grant date. |
Employee Stock Options (right to buy)
|
503,937 |
| 2026-02-19 | Lopez Carlos Luis |
SVP, General Counsel |
Award↑
Filing footnotes — Employee Stock Options (right to buy) (Direct)
One-fourth of the shares subject to the option shall vest on each anniversary of the grant date. |
Employee Stock Options (right to buy)
|
41,420 |
| 2025-11-14 | Pamir Ozan |
CFO |
Buy↑
|
Common Stock
(I)
|
2,220 |
| 2025-11-14 | Pamir Ozan |
CFO |
Buy↑
Filing footnotes — Common Stock (Direct)
The weighted average purchase price for the transaction reported was $6.81, and the range of prices were between $6.7975 and $6.82, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range above will be provided. |
Common Stock
|
4,464 |
| 2025-06-24 | Jaksch Frank L Jr |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 24, 2026. |
Stock Option (right to buy)
|
20,000 |
| 2025-06-24 | Cohen Ann |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 24, 2026. |
Stock Option (right to buy)
|
20,000 |
| 2025-06-24 | YU Wing Tak Wendy |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 24, 2026. |
Stock Option (right to buy)
|
20,000 |
| 2025-06-24 | Patrick Kristin |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 24, 2026. |
Stock Option (right to buy)
|
20,000 |
| 2025-06-24 | Shahbazi Hamed |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 24, 2026. |
Stock Option (right to buy)
|
20,000 |
| 2025-06-24 | Ng Wang Yu Gary |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 24, 2026. |
Stock Option (right to buy)
|
20,000 |
| 2025-06-24 | Rubin Steven D |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 24, 2026. |
Stock Option (right to buy)
|
20,000 |
| 2025-04-09 | Fried Robert N |
Director, Chief Executive Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
The Reporting Person exercised the stock options reported on this Form 4 in advance of their expiration on July 29, 2025, paying the exercise price with cash, and has not sold any of the shares received upon exercise. |
Common Stock
|
66,667 |
| 2025-04-09 | Fried Robert N |
Director, Chief Executive Officer |
Convert↓
|
Stock Options (right to buy)
|
66,667 |
| 2025-03-07 | Lopez Carlos Luis |
SVP, General Counsel |
Buy↑
|
Common Stock
|
273 |
| 2025-02-25 | Fried Robert N |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Performance Stock Unit (Direct)
Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the company's common stock when vested. The PSUs vest incrementally upon the Company's common stock achieving specified price per share performance goals and continued employment prior to February 25, 2032, and subject to a change in control. |
Performance Stock Unit
|
1,518,600 |
| 2025-02-12 | Fried Robert N |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Employee Stock Options (right to buy) (Direct)
One-third of the shares subject to the option shall vest on February 12, 2026 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter. |
Employee Stock Options (right to buy)
|
492,278 |
| 2025-02-12 | Lopez Carlos Luis |
SVP, General Counsel |
Award↑
Filing footnotes — Employee Stock Options (right to buy) (Direct)
One-third of the shares subject to the option shall vest on February 12, 2026 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter. |
Employee Stock Options (right to buy)
|
19,691 |
| 2025-02-12 | Pamir Ozan |
CFO |
Award↑
Filing footnotes — Employee Stock Options (right to buy) (Direct)
One-third of the shares subject to the option shall vest on February 12, 2026 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter. |
Employee Stock Options (right to buy)
|
17,230 |
| 2024-12-13 | Jaksch Frank L Jr |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The weighted average sale price for the transaction reported was $6.1881, and the range of prices were between $6.13 and $6.285. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. The sale of shares was solely to cover the exercise cost and associated taxes for the exercise of the options which were scheduled to expire on July 5, 2025. As a result of the exercise of the options, the Reporting Person will own 12,840 more shares. |
Common Stock
|
37,161 |
| 2024-12-13 | Jaksch Frank L Jr |
Director |
Convert↓
|
Employee Stock Options (right to buy)
|
50,001 |
| 2024-12-13 | Jaksch Frank L Jr |
Director |
Convert↑
|
Common Stock
|
50,001 |
| 2024-11-22 | Pamir Ozan |
CFO |
Buy↑
Filing footnotes — Common Stock (Direct)
The weighted average purchase price for the transaction reported was $7.36, and the range of prices were between $7.345 and $7.36, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range above will be provided. |
Common Stock
|
2,907 |
| 2024-10-21 | Pamir Ozan |
CFO |
Award↑
Filing footnotes — Employee Stock Options (right to buy) (Direct)
One-third of the shares subject to the option shall vest on October 21, 2025 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter. |
Employee Stock Options (right to buy)
|
146,544 |
| 2024-10-21 | Pamir Ozan |
CFO |
Other↑
|
No Securities Owned
|
0 |
| 2024-08-23 | Patrick Kristin |
Director |
Convert↓
|
Stock Option (right to buy)
|
3,000 |
| 2024-08-23 | Patrick Kristin |
Director |
Convert↓
|
Stock Option (right to buy)
|
20,000 |
| 2024-08-23 | Patrick Kristin |
Director |
Convert↑
|
Common Stock
|
3,000 |
| 2024-08-23 | Patrick Kristin |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The weighted average sale price for the transaction reported was $3.57, and the range of prices were between $3.52 and $3.64. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
Common Stock
|
23,000 |
| 2024-08-23 | Patrick Kristin |
Director |
Convert↑
|
Common Stock
|
20,000 |
| 2024-08-20 | Chau Hoi Shuen Solina Holly |
10% Owner |
Buy↑
Filing footnotes — Common Stock (Indirect)
On August 20, 2024, Brilliant Dynasty Limited, a British Virgin Islands corporation ("Brilliant Dynasty") entered into a securities purchase agreement with Prime Tech Global Limited, a British Virgin Islands corporation ("Prime Tech") and Alpha Mount International Limited, a British Virgin Islands corporation ("Alpha") to purchase all of the share capital of Champion River Ventures Limited, a British Virgin Islands corporation ("Champion River"), Winsave Resources Limited, a British Virgin Islands corporation ("Winsave"), and Radiant Treasure Limited, a British Virgin Islands corporation ("Radiant") from Prime Tech and Alpha, for an aggregate consideration of $32,058,489.15 (the "August 2024 Transaction"). At time of entry into the securities purchase agreement, Champion River, Winsave and Radiant beneficially owned 7,940,937, 3,088,433 and 379,345 shares of common stock of the Issuer, respectively. Of the total shares beneficially owned following the reported transaction (i) 6,917,783 shares of the Issuer's common stock are directly beneficially owned by Pioneer Step Holdings Limited, a British Virgin Islands corporation ("Pioneer Step"), (ii) 420,000 shares of the Issuer's common stock are directly beneficially owned by Dvorak International Limited ("Dvorak International"), (iii) 547,858 shares of the Issuer's common stock are directly beneficially owned by Skyinvest Associates Limited ("Skyinvest Associates"), (iv) 7,940,937 shares of the Issuer's common stock are directly beneficially owned by Champion River, (v) 3,088,433 shares of the Issuer's common stock are directly beneficially owned by Winsave, and (vi) 379,345 shares of the Issuer's common stock are directly beneficially owned by Radiant. (continued from Footnote 2) Elgar International Limited, a British Virgin Islands corporation ("Elgar International") is the sole shareholder of Brilliant Dynasty. Brilliant Dynasty will be the sole shareholder of Champion River, Winsave and Radiant upon the completion of the August 2024 Transaction. As such, each of Elger International and Brilliant Dynasty may be deemed to beneficially own the shares of the Issuer's common stock directly held by Champion River, Winsave and Radiant. Chau Hoi Shuen Solina Holly ("Solina Chau") is the sole shareholder of each of Pioneer Step, Dvorak International, Skyinvest Associates and Elgar International. As such, Solina Chau may be deemed to beneficially own the shares of the Issuer's common stock directly held by Pioneer Step, Dvorak International, Skyinvest Associates, Champion River, Winsave and Radiant. |
Common Stock
(I)
|
11,408,715 |
| 2024-08-20 | Li Ka Shing |
10% Owner |
Sell↓
Filing footnotes — Common Stock (Indirect)
On August 20, 2024, Prime Tech Global Limited, a British Virgin Islands corporation ("Prime Tech") and Alpha Mount International Limited, a British Virgin Islands corporation ("Alpha") entered into a securities purchase agreement with Brilliant Dynasty Limited, a British Virgin Islands corporation ("Brilliant Dynasty"), to sell all of the share capital of Champion River Ventures Limited, a British Virgin Islands corporation ("Champion River"), Winsave Resources Limited, a British Virgin Islands corporation ("Winsave") and Radiant Treasure Limited, a British Virgin Islands corporation ("Radiant") to Brilliant Dynasty, for an aggregate consideration of $32,058,489.15. At time of entry into the securities purchase agreement, Champion River, Winsave and Radiant beneficially owned 7,940,937, 3,088,433 and 379,345 shares of common stock of the Issuer, respectively. The sole shareholder of Prime Tech is Mayspin Management Limited ("Mayspin"), and the sole shareholder of Mayspin is Li Ka Shing. The sole shareholder of Alpha is Apex Dynasty Limited, a British Virgin Islands corporation ("Apex"), and the sole shareholder of Apex is Li Ka Shing. |
Common Stock
(I)
|
11,408,715 |
| 2024-06-20 | Shahbazi Hamed |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 20, 2025. |
Stock Option (right to buy)
|
20,000 |
| 2024-06-20 | Cohen Ann |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 20, 2025. |
Stock Option (right to buy)
|
20,000 |
| 2024-06-20 | Jaksch Frank L Jr |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 20, 2025. |
Stock Option (right to buy)
|
20,000 |
| 2024-06-20 | Ng Wang Yu Gary |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 20, 2025. |
Stock Option (right to buy)
|
20,000 |
| 2024-06-20 | Patrick Kristin |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 20, 2025. |
Stock Option (right to buy)
|
20,000 |
| 2024-06-20 | Rubin Steven D |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Option vests 100% on June 20, 2025. |
Stock Option (right to buy)
|
20,000 |